Atıf Formatları
Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. Okutucu Et Al. , "Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’," Europace , vol.19, no.5, pp.741-746, 2017

Okutucu, S. Et Al. 2017. Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’. Europace , vol.19, no.5 , 741-746.

Okutucu, S., Katircioglu-Öztürk, D., Oto, E., Güvenir, H. A., Karaagaoglu, E., Oto, A., ... Meinertz, T.(2017). Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’. Europace , vol.19, no.5, 741-746.

Okutucu, Sercan Et Al. "Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’," Europace , vol.19, no.5, 741-746, 2017

Okutucu, Sercan Et Al. "Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’." Europace , vol.19, no.5, pp.741-746, 2017

Okutucu, S. Et Al. (2017) . "Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’." Europace , vol.19, no.5, pp.741-746.

@article{article, author={Sercan Okutucu Et Al. }, title={Data mining experiments on the Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF-AFNET 2) trial: ‘Exposing the invisible’}, journal={Europace}, year=2017, pages={741-746} }